【财华社讯】中国中药(00570.HK)公布，截至2023年12月31日止年度，营业额合计人民币181.22亿元(单位,下同)，同比增长26.7%。母公司拥有人应占溢利12.85亿元，同比增长68.11%。每股基本盈利25.52分。不派息。
中国中药(00570.HK)年度归母净利12.85亿人民币 不派息
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.